Mucin 1-mediated chemo-resistance in lung cancer cells

Paclitaxel (PTX) is a commonly used drug to treat diverse cancer types. However, its treatment can generate resistance and the mechanisms of PTX-resistance in lung cancers are still unclear. We demonstrated that non-small cell lung cancers (NSCLCs) survive PTX treatment. Compared with the progenitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ham, S Y, Kwon, T, Bak, Y, Yu, J-H, Hong, J, Lee, S K, Yu, D-Y, Yoon, D-Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728677/
https://www.ncbi.nlm.nih.gov/pubmed/26779808
http://dx.doi.org/10.1038/oncsis.2015.47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728677/
https://www.ncbi.nlm.nih.gov/pubmed/26779808
http://dx.doi.org/10.1038/oncsis.2015.47

Ejemplares similares